| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.097 | 0.004 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.21 | 0.004 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.004 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.005 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.006 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.098 | 0.006 |